Exit Strategies for Life Sciences and MedTech Startups

Van derden

19/05/22

Has your life sciences or medtech startup identified their long-term exit strategy, including strategic endgame and plan for getting there? Johnson & Johnson Innovation will provide a no-nonsense guide to key aspects of exits as the market-leading technology team from Allen & Overy shares deep insights in M&A from different global ecosystems.

Join us in Leiden, the Netherlands, or virtually: https://jji.jnj/exitstrategies